Previse

About:

Previse is a life sciences company focused on the development and commercialization of diagnostic tests for cancer prevention.

Website: https://previsedx.com/

Top Investors: Gaingels, TEDCO, National Cancer Institute, Riptide Ventures, National Institute of Diabetes and Digestive and Kidney Diseases

Description:

Previse is a biotechnology company that specializes in the fields of diagnostics, medical devices, medicine, early detection, and Medtech. The company was founded in 2020 and is headquartered in Baltimore, Maryland.

Total Funding Amount:

$8.05M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Baltimore, Maryland, United States

Founded Date:

2020-01-01

Contact Email:

info(AT)capsulomics.com

Founders:

Daniel Lunz, Stephen J. Meltzer

Number of Employees:

11-50

Last Funding Date:

2024-10-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai